Literature DB >> 16106585

Therapeutic cancer vaccines.

Fleur Pijpers, Richard Faint, Nish Saini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16106585     DOI： 10.1038/nrd1802

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Rethinking therapeutic cancer vaccines.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

2.  Synthetic Immunobiotics: A Future Success Story in Small Molecule-Based Immunotherapy?

Authors:  Mary J Sabulski Feigman; Marcos M Pires
Journal:  ACS Infect Dis       Date:  2018-02-16       Impact factor: 5.578

3.  Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.

Authors:  Huijuan Song; Pengxiang Yang; Pingsheng Huang; Chuangnian Zhang; Deling Kong; Weiwei Wang
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

4.  Immune response to sipuleucel-T in prostate cancer.

Authors:  Eddie Thara; Tanya B Dorff; Monica Averia-Suboc; Michael Luther; Mary E Reed; Jacek K Pinski; David I Quinn
Journal:  Cancers (Basel)       Date:  2012-04-18       Impact factor: 6.639

5.  Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.

Authors:  Xiaobo Xi; Lijun Zhang; Guihong Lu; Xiaoyong Gao; Wei Wei; Guanghui Ma
Journal:  J Immunol Res       Date:  2018-06-19       Impact factor: 4.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.